NCT01042262

Brief Summary

When exposed to oxygen immediately after birth, newborns suffer from an oxidative stress with a significant decrease in serum concentration of the anti-oxidant enzyme superoxide dismutase. This oxidative stress has been consequently linked to the development of adverse outcomes in both premature and full term infants. In this study, we examined the effect of oxygen administration to delivering mothers immediately before and during labor on the newborn. In this randomized trial, we planned to measure superoxide dismutase in the umbilical cord blood when mothers received and did not receive oxygen..

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2007

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2009

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 21, 2009

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 5, 2010

Completed
Last Updated

January 5, 2010

Status Verified

December 1, 2009

Enrollment Period

2.2 years

First QC Date

December 21, 2009

Last Update Submit

January 4, 2010

Conditions

Keywords

Superoxide dismutaseOxygenOxygen free radicalsLabor and delivery

Outcome Measures

Primary Outcomes (1)

  • Superoxide dismutase concentration in umbilical cord blood

    within 4 hours

Secondary Outcomes (1)

  • Superoxide dismutase concentration in maternal venous blood after delivery

    within 4 hours

Study Arms (2)

Oxygen Group

EXPERIMENTAL

Subjects received 100% oxygen via nasal cannula (flow =2 L/min)

Other: Oxygen

Control Group

PLACEBO COMPARATOR

Subjects were attached to a nasal cannula without any oxygen flow.

Other: Placebo

Interventions

OxygenOTHER

100% Oxygen at a flow of 2 L/min

Oxygen Group
PlaceboOTHER

No oxygen flow

Control Group

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • uncomplicated pregnancy
  • term gestational age from completed 37 weeks to 42 weeks, and
  • normal spontaneous vaginal delivery or elective caesarean section

You may not qualify if:

  • hypertension, or eclampsia
  • diabetes
  • anemia
  • other medical or surgical complications during the current pregnancy
  • rupture of amniotic membranes for more than 18 hours
  • history of infants with invasive group B Streptococcal disease in previous pregnancies
  • fetal distress before delivery, and
  • suspected chromosomal, and structural anomalies or congenital infections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The George Washington University Hospital

Washington D.C., District of Columbia, 20037, United States

Location

Related Publications (1)

  • Nesterenko TH, Acun C, Mohamed MA, Mohamed AN, Karcher D, Larsen J Jr, Aly H. Is it a safe practice to administer oxygen during uncomplicated delivery: a randomized controlled trial? Early Hum Dev. 2012 Aug;88(8):677-81. doi: 10.1016/j.earlhumdev.2012.02.007. Epub 2012 Mar 23.

MeSH Terms

Conditions

Fetal Distress

Interventions

Oxygen

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

ChalcogensElementsInorganic ChemicalsGases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 21, 2009

First Posted

January 5, 2010

Study Start

February 1, 2007

Primary Completion

May 1, 2009

Study Completion

August 1, 2009

Last Updated

January 5, 2010

Record last verified: 2009-12

Locations